Jian‐Ching Wu

621 total citations
18 papers, 472 citations indexed

About

Jian‐Ching Wu is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jian‐Ching Wu has authored 18 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Jian‐Ching Wu's work include Fibroblast Growth Factor Research (6 papers), melanin and skin pigmentation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jian‐Ching Wu is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), melanin and skin pigmentation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jian‐Ching Wu collaborates with scholars based in Taiwan, Australia and Netherlands. Jian‐Ching Wu's co-authors include Ming‐Hong Tai, Zhi‐Hong Wen, Tian‐Huei Chu, Mei‐Lang Kung, Feng‐Sheng Wang, Chieh‐Shan Wu, Shih‐Chung Huang, Wei‐Shiung Lian, Chung-Wen Kuo and Jih‐Yang Ko and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and The FASEB Journal.

In The Last Decade

Jian‐Ching Wu

18 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jian‐Ching Wu Taiwan	12	260	111	74	63	63	18	472
Lian Tang China	14	282 1.1×	173 1.6×	48 0.6×	43 0.7×	36 0.6×	44	507
Li Cai China	11	232 0.9×	82 0.7×	107 1.4×	39 0.6×	45 0.7×	21	483
Weihong Yin United States	12	254 1.0×	107 1.0×	98 1.3×	146 2.3×	34 0.5×	15	498
Titus Sparna Germany	7	204 0.8×	64 0.6×	44 0.6×	42 0.7×	52 0.8×	8	417
Astrid Weiß Germany	14	282 1.1×	72 0.6×	74 1.0×	22 0.3×	53 0.8×	31	689
Yongjun Fang China	17	479 1.8×	273 2.5×	106 1.4×	53 0.8×	63 1.0×	75	852
Sabrina Priam France	7	190 0.7×	65 0.6×	72 1.0×	175 2.8×	46 0.7×	13	458
Hai-Yang Liao China	10	213 0.8×	84 0.8×	78 1.1×	31 0.5×	58 0.9×	20	469
Tetsuhiro Horie Japan	14	282 1.1×	85 0.8×	132 1.8×	48 0.8×	51 0.8×	37	459
Kuang‐Tzu Huang Taiwan	14	285 1.1×	149 1.3×	101 1.4×	16 0.3×	45 0.7×	38	528

Countries citing papers authored by Jian‐Ching Wu

Since Specialization

Citations

This map shows the geographic impact of Jian‐Ching Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Ching Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Ching Wu more than expected).

Fields of papers citing papers by Jian‐Ching Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Ching Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Ching Wu. The network helps show where Jian‐Ching Wu may publish in the future.

Co-authorship network of co-authors of Jian‐Ching Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Ching Wu. A scholar is included among the top collaborators of Jian‐Ching Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Ching Wu. Jian‐Ching Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Weng, Shao‐Wen, Jian‐Ching Wu, Feng‐Chih Shen, et al.. (2023). Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation. Diabetologia. 66(5). 913–930. 25 indexed citations

Wu, Jian‐Ching, Chao‐Cheng Huang, Pei‐Wen Wang, et al.. (2023). ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN. International Journal of Molecular Sciences. 24(2). 1649–1649. 5 indexed citations

Hu, Tsung‐Hui, Jian‐Ching Wu, Shih‐Tsung Huang, et al.. (2023). HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria. Journal of Biological Chemistry. 299(11). 105335–105335. 5 indexed citations

Chu, Tian‐Huei, Yi‐Chen Chang, Chao‐Cheng Huang, et al.. (2022). Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma. Journal of Biological Chemistry. 298(10). 102442–102442. 7 indexed citations

Wu, Chieh‐Shan, et al.. (2020). Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells. International Journal of Molecular Sciences. 21(21). 7892–7892. 16 indexed citations

Wu, Jian‐Ching, et al.. (2020). Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition. International Journal of Molecular Sciences. 21(2). 681–681. 4 indexed citations

Wang, E‐Ming, Tsung‐Hui Hu, Chao‐Cheng Huang, et al.. (2020). Hepatoma‐derived growth factor participates in concanavalin A‐induced hepatitis. The FASEB Journal. 34(12). 16163–16178. 7 indexed citations

Wang, Feng‐Sheng, Chung-Wen Kuo, Jih‐Yang Ko, et al.. (2020). Irisin Mitigates Oxidative Stress, Chondrocyte Dysfunction and Osteoarthritis Development through Regulating Mitochondrial Integrity and Autophagy. Antioxidants. 9(9). 810–810. 122 indexed citations

Chu, Tian‐Huei, Shih‐Tsung Huang, Sheau‐Fang Yang, et al.. (2019). Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis. Oncogene. 38(37). 6461–6477. 35 indexed citations

10.

Lin, Yu‐Wei, Shih‐Tsung Huang, Jian‐Ching Wu, et al.. (2019). Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis. BMC Cancer. 19(1). 1083–1083. 37 indexed citations

11.

Wu, Jian‐Ching, et al.. (2018). Autophagic cell death participates in POMC-induced melanoma suppression. Cell Death Discovery. 4(1). 11–11. 11 indexed citations

12.

Weng, Wen‐Tsan, Chieh‐Shan Wu, Feng‐Sheng Wang, et al.. (2018). α-Melanocyte-Stimulating Hormone Attenuates Neovascularization by Inducing Nitric Oxide Deficiency via MC-Rs/PKA/NF-κB Signaling. International Journal of Molecular Sciences. 19(12). 3823–3823. 17 indexed citations

13.

Chu, Tian‐Huei, Hoi‐Hung Chan, Tsung‐Hui Hu, et al.. (2018). Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats. Cancer Medicine. 7(6). 2567–2580. 30 indexed citations

14.

Wu, Jian‐Ching, Han-Chun Hung, Wen‐Jeng Wu, et al.. (2016). Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells. The Prostate. 76(16). 1469–1483. 40 indexed citations

15.

Liu, Guei‐Sheung, Jian‐Ching Wu, Gregory J. Dusting, et al.. (2014). Proopiomelanocortin gene delivery induces apoptosis in melanoma through NADPH oxidase 4-mediated ROS generation. Free Radical Biology and Medicine. 70. 14–22. 15 indexed citations

16.

Weng, Wen‐Tsan, Shih‐Chung Huang, Hoi‐Hung Chan, et al.. (2014). α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(6). 1850–1860. 14 indexed citations

17.

Liu, Guei‐Sheung, Mei‐Lang Kung, Lifeng Liu, et al.. (2013). Downregulation of Hepatoma-Derived Growth Factor Contributes to Retarded Lung Metastasis via Inhibition of Epithelial–Mesenchymal Transition by Systemic POMC Gene Delivery in Melanoma. Molecular Cancer Therapeutics. 12(6). 1016–1025. 27 indexed citations

18.

Kung, Mei‐Lang, Tsung‐Hui Hu, Hsuan‐Yu Chen, et al.. (2012). Hepatoma‐derived growth factor regulates breast cancer cell invasion by modulating epithelial–mesenchymal transition. The Journal of Pathology. 228(2). 158–169. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact